dynaga partner buy pt distribut cut still yield rais estim tight
market lower pt maintain buy analyst jame jang full summari
 buy pt preview slight estim reduct weather turnaround
 buy pt ep vs consensu unusu wide nim
reiter buy rate price analyst michael diana full summari
 buy pt still expect modest addit upsid potenti
larg short float maintain buy pt analyst stephen anderson full summari
intellipharmaceut intern inc ipci hold focus pipeline- podra analyst jason mccarthi
isoray inc isr buy pt resurg brachytherapi shift soc brain cancer treatment
inc buy pt ep vs consensu solid quarter reiter buy
rate price analyst michael diana full summari
corpor event call maxim salesperson inform
inc cover confer call presid scott colosi senior director
ir/financi report tonya robinson mon may
inc cover confer call cfo kate jaspon presid david
cover ndr boston cfo golder wed jun
corpor ctrl cover chokshi ndr boston ct nyc cfo mark novakovich mon-w
identiv inc host chokshi group dinner nyc ceo stephen humphrey cfo sarah wallach
annual silicon valley bu tour host chokshi tue juli
potenti larg short float maintain buy pt
maintain buy rate price target cheesecak factori
ahead releas march result wednesday april
maintain ep estim comp
also maintain ep estim outlook vs
guidanc comp
see potenti upsid ep guidanc benign food cost
still see upsid price target moreov share could
benefit short-cov ralli given short posit float
maintain ep estim vs consensu
guidanc although reduc comp estim slightli
vs consensu posit guidanc due primarili
weather believ cake exposur warm-weath market california
texa florida nevada arizona compris combin cake total
unit count mitig weather-rel slowdown moreov accord knapp-
track california texa florida outperform market
past sever quarter
one potenti neg see y/i declin box offic receipt
broader slate hit movi howev anticip stronger
movi schedul next coupl quarter compar y/i box
offic receipt fell view box offic receipt
potenti factor sale compani highest exposur
adjac movi theater among nation casual dine concept locat
within develop movi theater
also maintain outlook ep vs consensu
guidanc comp vs consensu posit
guidanc expect driven mix improv macroeconom
backdrop company-specif initi design drive sale part
believ sever top-lin lever dispos includ mobil order
launch nationwid off-premis sale locat offer deliveri
saturday brunch accord model annual comp
translat ep upsid els equal
see potenti upsid ep guidanc benign food cost sg
expens control although maintain guidanc food cost inflat
last earn report februari believ stabl corn wheat feed
price tend lead dairi price month protein price month
portend benign food cost rel initi guidanc
estim moder food cost inflat outlook add
ep moreov estim return averag sg
spend total sale would add much annual ep
ralli strongli fall low though still see upsid
price target unchang price target base sum-of-
part methodolog correspond forward price-to-earnings vs five-year averag
forward ev/ebitda ratio vs five-year averag
one highest short posit coverag univers float
compar industri averag believ posit result potenti
click full note
preview slight estim reduct weather
maintain buy rate price target chipotl mexican grill
ahead releas march result wednesday april
lower ep estim vs consensu
lower quarterli comp estim vs
nevertheless still expect cmg full-year comp run
pace vs consensu result ep vs prior
manag emphas buyback expect buyback
signific ep driver
lower ep estim lower quarterli
comp estim factor remain overlap chiptopia
cmg promot giveaway relat comp growth weather-
relat traffic weak east mid-west januari march
estim reduc traffic much nevertheless model
inflect point two-year stack comp would mark first
time two year post posit two-year stack comp
also believ margin support benign commod cost recent
protein avocado well recent menu price increas
nevertheless still expect cmg full-year comp run pace
result ep anticip return robust sale earn
growth next quarter help part increas technology-en
sale estim could reach mid-teen percentag total sale
year-end higher off-premis cater deliveri sale new
menu offer believ could includ current test item nacho
frozen beverag near-term expect initi detail
januari compani report think could receiv boost
new ceo brian niccol new chri brandt former underl mr
niccol support much increment
comp growth next two three year half model come
increas averag ticket regard margin expect combin
benign food cost improv restaurant-level effici help part
increas technology-driven off-premis sale off-set higher labor cost
manag emphas buyback expect buyback
signific ep driver accord model exhibit estim
buyback add ep much ep
still argu pullback share provid opportun investor
particip compani recoveri multipli forward price-to-earnings target
revis ep estim vs arriv price target
round correspond forward ev/ebitda ratio
long-run averag garner prior coli
outbreak cmg short float percentag total float
weight industri averag better-than-expect result
updat guidanc potenti trigger short-cov ralli
click full note
distribut cut still yield rais
estim tight market lower pt
dynaga partner announc cut quarterli
distribut assum compani would look
issu prefer equiti plu sponsor seller credit execut drop
asset could kept distribut unchang
addit adjust option fleet valu accrual reflect lower
premium adjust financ assumpt
reflect million debt remain drop
candid therefor lower price target
base updat target prior
spoke manag follow releas mention
prioriti refin million note due
distribut cut made preserv capit
enabl dlng replac exist facil favor term
although drop down import growth strategi dlng expect
manag revisit strategi overhang
near-term capit need remov equiti valu stabil
howev rais estim expect sector
tighten
prioriti chang drop asset refinanc
million note yesterday pre-market open dlng announc cut quarterli
distribut per common unit took contrarian stanc
distribut assum dlng would look issu prefer equiti combin
seller credit sponsor execut drop option vessel support
current distribut level howev call manag reiter
near-term prioriti refin million note due assum
distribut cut help preserv cash reserv ahead refinanc
rais estim sector seem tighten follow
stronger-than-expect rate expect sector benefit increas
spot cargo base cove point sabin pass oper
could increas util ton-mil demand therefor rais
estim expect revenu million million prior
ebitda million million prior earn per common unit
sell-off present opportun distribut yield still declin
share yesterday follow news distribut cut present opportun
view highlight dlng consist track record distribut
payment straight quarterli distribut despit cut current
distribut yield
valuat although rais estim lower
price target new price target base option valu
accrual formula adjust lower distribut payment equat new
forward normal target prior share current
trade discount target maintain buy rate
click full note
ep vs consensu unusu wide
nim reiter buy rate price target
result elev unusu wide nim due purchas
account accret share buyback
rais ep estim reflect
result well continu strong core earn momentum
maintain price target price target
price-to-earnings would versu small-cap peer believ
deserv premium valuat base superior non-interest incom
contribut core deposit fund net interest margin well
record success integr two materi acquisit past two
result summari april post-clos report ep
versu consensu view solid quarter beat
driven strong net interest margin nim elev unusu high
level favor outcom loan previous mark acquisit share
buyback also made contribut credit qualiti remain solid view net
charge-off averag loan non-performing asset equal
loan core effici ratio
partli due competit market-bas wage increas
lead independ bank valley merger-of-equ
baylak corp acquisit first menasha bancshar posit
lead independ bank demograph attract area
green bay valley
rais ep estim reflect result well
continu strong core earn momentum new estim base
nim loan growth core effici ratio stabl credit qualiti tax
rate page updat earn model
maintain price target price target ncbss price-to-earnings
would versu peer believ deserv premium
valuat base superior non-interest incom contribut core deposit fund
net interest margin well record success integr two materi
acquisit past two year
reiter buy rate next four quarter expect stock price
appreci price target result estim total return
click full note
focus pipeline- podra
revenu nov ye declin
owe larg declin gener focalin sale cite price pressur
us gener market ipci recent rais equiti financ
extend runway howev believ time
gener busi ipci continu grow provid revenu
help off-set cash burn associ key program abus deterr
oxycodon podra prevent overdos view program
long-term driver compani
move forward recal ipci receiv codon er
drove valuat near low commonplac
abuse-resist oxycodon space believ due fda
caution regard new opioid approv given on-going opioid crisi
ultim believ ipci product other gain approv
compani prepar studi support refil nda
podra go clinic podra technolog could potenti
prevent drug overdos reduc bioavail drug invers
dose taken take less work could shift paradigm
drug deliveri problem thu far test human sinc would
requir intent high dose drug howev clinic program
design test technolog safe initi expect
could see data year
conclus focu pipeline- oxycodon podra view
gener revenu disappoint quarter expect busi
grow new product launch provid meaning revenu offset burn
pipelin program podra studi re-fil nda next
oxycodon er stori thu far recal advisori panel committe
express desir review addit safeti efficaci data oxycodon er
may obtain human abus potenti studi oral intranas
rout administr ipci conduct categori pk categori abus potenti
studi provid data believ necessari support abuse-deterr
properti oxycodon er oral intranas rout requir
abuse-deterr label claim rout follow discuss fda
compani move forward oxycodon er without blue dye
origin intend prevent abus serv earli warn sign potenti
misus drug per patent infring claim launch purdu pharma
fda stay grant approv unless purdu patent
declar invalid infring court date set regard infring
claim ipci manag believ well-prepar defend
claim
technolog could chang dynam entir drug landscap idea
take mani pill still result therapeut effect one pill
drug overdos occur opioid also commonli use drug
like tylenol ipci activ discuss appropri clinic trial design fda
clinic
click full note
ep vs consensu solid quarter
reiter buy rate price target
newly-announc acquisit springfield bancshar missouri
expect increas asset accret ep
price target equat ep estim versu
small-cap peer view deserv trade premium peer
given above-p core deposit fund cost fund net interest margin
effici ratio well success acquisit record
result summari today pre-open report ep versu
consensu loan strong linked-quart expens
integr guaranti bank trust compani cedar rapid iowa
complet core effici ratio flat core net interest margin
nim adjust tax law chang help fed fund rate increas
manag guid stabl nim remaind
credit qualiti credit qualiti remain solid view non-performing asset
npa unchang loan versu net chargeoff
averag loan due one larg credit put non-accru
move oreo loan loss reserv equal
npa includ purchas account discount acquir loan
acquisit springfield bancshar springfield missouri announc
morn increas asset accret ep
springfield metropolitan market good growth prospect
springfield bancshar strong track record earn growth combin
excel credit qualiti accordingli acquisit multipl ltm earn
tangibl book valu appear us reason transact expect
close chang ep estim time
maintain ep estim base nim loan
growth core effici ratio stabl credit qualiti effect tax rate
page updat earn model
maintain price target equat ep estim
versu averag price-to-earnings small-cap peer bank view
deserv trade premium peer given above-p core deposit fund cost
fund net interest margin effici ratio well success acquisit
reiter buy rate next four quarter expect stock price
appreci price target dividend yield
result estim total return note
rais quarterli dividend per share
click full note
resurg brachytherapi shift soc brain
isoray report preliminari june ye result continu sequenti
growth revenu rose y/i
estim margin continu rise manag expect
less growth revenu manag execut
busi plan good let discuss drive growth
believ continu
four area focu detail page
shorter half-lif higher energi kill tumor spare healthi
tissu vs soc isotop isoray produc
brachytherapi market prostat cancer pc seed market declin
driven aggress use ebr extern beam radiat howev
effect pc emerg soc isoray stand
beneficiari view
brain cancer shift soc gammatil place
tumor bed time surgeri deliv radiat right away vs
wait day current soc day window critic
brain cancer alreadi grow
pipelin gynecolog cancer tumor type
conclus isoray continu execut busi plan
revenu continu steadi climb upward new emerg data
prostat cancer posit seed market turnaround platform
gammatil could shift soc brain cancer believ isoray
posit continu grow time drive sharehold valu
brachytherapi market pois grow deposit brachytherapi
seed per patient load radio-isotop like emerg
standard care soc altern radic prostatectomi
ebr ebr urinari burn pain dose limit seed
ideal ebr technolog improv reimburs higher
despit ebr seed compar tumor kill higher reimburs may
driven urologist ebr howev pc slow grow diseas new long-term
data demonstr combin brachytherapi ebr reduc recurr
vs ebr alon data emerg case use combin
therapi soc support posit brachytherapi market thu
isoray grow
market meningioma brain metastas glioblastoma patient
soc surgeri follow radiat day patient time heal
challeng time tumor alreadi grown grow back
seed place brain half-lif long
would destroy healthi tissu use
short day half-lif isoray gammatil place
tumor bed surgeri ad minut procedur deliv
radiat immedi vs wait day proof concept demonstr
barrow neurolog institut mesh data demonstr
local control brain cancer signific improv soc gammatil
summer launch
click full note
maxim analyst coverag univers
